Skip to main content


Page 2 of 60

  1. The triglyceride-glucose (TyG) index is considered a dependable biomarker for gauging insulin resistance. The atherogenic index of plasma (AIP) represents a marker reflecting atherosclerosis. However, there is...

    Authors: Xiaosheng Wu, Weiping Qiu, Huancheng Yang, Yan-Jun Chen, Jianling Liu and Guojun Zhao
    Citation: Cardiovascular Diabetology 2024 23:76
  2. Early since the onset of the COVID-19 pandemic, the medical and scientific community were aware of extra respiratory actions of SARS-CoV-2 infection. Endothelitis, hypercoagulation, and hypofibrinolysis were i...

    Authors: Inés Valencia, Jairo Lumpuy-Castillo, Giselle Magalhaes, Carlos F. Sánchez-Ferrer, Óscar Lorenzo and Concepción Peiró
    Citation: Cardiovascular Diabetology 2024 23:75
  3. Stress hyperglycemia ratio (SHR) has recently been recognized as a novel biomarker that accurately reflects acute hyperglycemia status and is associated with poor prognosis of heart failure. We evaluated the r...

    Authors: Xiangming Hu, Dejing Feng, Yuxuan Zhang, Can Wang, Yang Chen, Guannan Niu, Zheng Zhou, Zhenyan Zhao, Hongliang Zhang, Moyang Wang and Yongjian Wu
    Citation: Cardiovascular Diabetology 2024 23:73
  4. The 2022 Canadian Cardiovascular Society (CCS) cardiorenal guideline provided clinical recommendations on sodium-glucose co-transport 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1R...

    Authors: Muhammad Usman Ali, G. B. John Mancini, Donna Fitzpatrick-Lewis, Kim A. Connelly, Eileen O’Meara, Shelley Zieroth and Diana Sherifali
    Citation: Cardiovascular Diabetology 2024 23:72
  5. We assessed the efficacy and safety of enavogliflozin (0.3 mg), a newly developed SGLT-2 inhibitor, in patients with type 2 diabetes mellitus based on kidney function via pooled analysis of two 24-week, random...

    Authors: Young Sang Lyu, Sangmo Hong, Si Eun Lee, Bo Young Cho and Cheol-Young Park
    Citation: Cardiovascular Diabetology 2024 23:71
  6. Angiogenin, an enzyme belonging to the ribonucleases A superfamily, plays an important role in vascular biology. Here, we sought to study the association of plasma angiogenin and major adverse cardiovascular e...

    Authors: Resham L. Gurung, Sylvia Liu, Jian-Jun Liu, Yiamunaa M., Huili Zheng, Clara Chan, Keven Ang, Tavintharan Subramaniam, Chee Fang Sum and Su Chi Lim
    Citation: Cardiovascular Diabetology 2024 23:70
  7. Studies have demonstrated that coronary artery calcification on one hand and non-alcoholic fatty liver disease (NAFLD) on the other hand are strongly associated with cardiovascular events. However, it remains ...

    Authors: Damien Denimal, Maharajah Ponnaiah, Anne-Caroline Jeannin, Franck Phan, Agnès Hartemann, Samia Boussouar, Etienne Charpentier, Alban Redheuil, Fabienne Foufelle and Olivier Bourron
    Citation: Cardiovascular Diabetology 2024 23:69
  8. Gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (T2DM) share many pathophysiological factors including genetics, but whether epigenetic marks are shared is unknown. We aimed to test whether a ...

    Authors: Teresa M. Linares-Pineda, Nicolas Fragoso-Bargas, María José Picón, Maria Molina-Vega, Anne Karen Jenum, Line Sletner, Sindre Lee-Ødegård, Julia O. Opsahl, Gunn-Helen Moen, Elisabeth Qvigstad, Rashmi B. Prasad, Kåre I. Birkeland, Sonsoles Morcillo and Christine Sommer
    Citation: Cardiovascular Diabetology 2024 23:68
  9. Recent studies highlighted that stress hyperglycemia ratio (SHR) is a potential predictor for future risk in heart failure (HF) patients. However, its implications specifically in HF with preserved ejection fr...

    Authors: Abdul-Quddus Mohammed, Yongqiang Luo, Kaitao Wang, Yang Su, Lu Liu, Guoqing Yin, Wen Zhang, J Jiasuer. Alifu, Redhwan M. Mareai, Ayman A. Mohammed, Yawei Xu, Fuad A. Abdu and Wenliang Che
    Citation: Cardiovascular Diabetology 2024 23:67
  10. The triglyceride glucose (TyG) index is a new and low-cost marker to determine insulin resistant which may be a predictor of cardiovascular disease (CVD). Although available evidence showed that its associatio...

    Authors: Ghazaal Alavi Tabatabaei, Noushin Mohammadifard, Hamed Rafiee, Fatemeh Nouri, Asieh Maghami mehr, Jamshid Najafian, Masoumeh Sadeghi, Maryam Boshtam, Hamidreza Roohafza, Fahimeh Haghighatdoost, Marzieh Taheri and Nizal Sarrafzadegan
    Citation: Cardiovascular Diabetology 2024 23:66
  11. Heart failure (HF) is increasing at an alarming rate, primary due to the rising in aging, obesity and diabetes. Notably, individuals with type 1 diabetes (T1D) face a significantly elevated risk of HF, leading...

    Authors: María Teresa Julián, Alejandra Pérez-Montes de Oca, Josep Julve and Nuria Alonso
    Citation: Cardiovascular Diabetology 2024 23:65
  12. The TyG-BMI index, which is a reliable indicator of insulin resistance (IR), has been found to have a significant correlation with the occurrence of cardiovascular events. However, there still lacks study on t...

    Authors: Yi Hu, Yiting Zhao, Jing Zhang and Chaomin Li
    Citation: Cardiovascular Diabetology 2024 23:64
  13. Metabolic syndrome is characterized as the co-occurrence of interrelated cardiovascular risk factors, including insulin resistance, hyperinsulinemia, abdominal obesity, dyslipidemia and hypertension. Once week...

    Authors: Stephen J. Nicholls, Santiago Tofé, Carel W. le Roux, David A. D’Alessio, Russell J. Wiese, Imre Pavo, Katelyn Brown, Govinda J. Weerakkody, Meltem Zeytinoglu and Irene C. Romera
    Citation: Cardiovascular Diabetology 2024 23:63
  14. Currently, the differentiation between type 1 diabetes (T1D) and type 2 diabetes (T2D) is not straightforward, and the features of both types of diabetes coexist in one subject. This situation triggered the ne...

    Authors: Weronika Bielka, Agnieszka Przezak, Piotr Molęda, Ewa Pius-Sadowska and Bogusław Machaliński
    Citation: Cardiovascular Diabetology 2024 23:62
  15. Stress hyperglycemia and glycemic variability (GV) can reflect dramatic increases and acute fluctuations in blood glucose, which are associated with adverse cardiovascular events. This study aimed to explore w...

    Authors: Hao-ming He, Shu-wen Zheng, Ying-ying Xie, Zhe Wang, Si-qi Jiao, Fu-rong Yang, Xue-xi Li, Jie Li and Yi-hong Sun
    Citation: Cardiovascular Diabetology 2024 23:61
  16. Coronary microvascular dysfunction (CMD) is a frequent complication of diabetes mellitus (DM) characterized by challenges in both diagnosis and intervention. Circulating levels of microRNAs are increasingly re...

    Authors: Yihai Liu, Chongxia Zhong, Shan Chen, Yanan Xue, Zhonghai Wei, Li Dong and Lina Kang
    Citation: Cardiovascular Diabetology 2024 23:60
  17. The stress hyperglycaemic ratio (SHR), a new marker that reflects the true hyperglycaemic state of patients with acute coronary syndrome (ACS), is strongly associated with adverse clinical outcomes in these pa...

    Authors: Kui Li, Xueyuan Yang, Yunhang Li, Guanxue Xu and Yi Ma
    Citation: Cardiovascular Diabetology 2024 23:59
  18. Patients with diabetes mellitus have poor prognosis after myocardial ischemic injury. However, the mechanism is unclear and there are no related therapies. We aimed to identify regulators of diabetic myocardia...

    Authors: Yunhui Lv, Kai Li, Shuo Wang, Xiaokang Wang, Guangxin Yue, Yangyang Zhang, Xin Lv, Ping Zhao, Shiping Wang, Qi Zhang, Qiuju Li, Jinyan Zhu, Jubo Li, Peng Peng, Yue Li, Jiafei Luo…
    Citation: Cardiovascular Diabetology 2024 23:58
  19. No randomized clinical trials have directly compared the cardiorenal effectiveness of empagliflozin and GLP-1RA agents with demonstrated cardioprotective effects in patients with a broad spectrum of cardiovasc...

    Authors: Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz-Luyet, Julie M. Paik and Elisabetta Patorno
    Citation: Cardiovascular Diabetology 2024 23:57

    The Correction to this article has been published in Cardiovascular Diabetology 2024 23:103

  20. SGLT2 inhibitors and DPP4 inhibitors have been suggested to affect lipid metabolism. However, there are few randomized controlled trials comparing the effects on the lipid metabolism between the two types of a...

    Authors: Mototsugu Nagao, Jun Sasaki, Kyoko Tanimura-Inagaki, Ichiro Sakuma, Hitoshi Sugihara and Shinichi Oikawa
    Citation: Cardiovascular Diabetology 2024 23:56
  21. Hypoglycaemia has been shown to induce a systemic pro-inflammatory response, which may be driven, in part, by the adrenaline response. Prior exposure to hypoglycaemia attenuates counterregulatory hormone respo...

    Authors: Clementine E. M. Verhulst, Julia I. P. van Heck, Therese W. Fabricius, Rinke Stienstra, Steven Teerenstra, Rory J. McCrimmon, Cees J. Tack, Ulrik Pedersen-Bjergaard and Bastiaan E. de Galan
    Citation: Cardiovascular Diabetology 2024 23:55
  22. The atherogenic index of plasma (AIP) and cardiovascular disease (CVD) in participants with abnormal glucose metabolism have been linked in previous studies. However, it was unclear whether AIP control level a...

    Authors: Qianqian Min, Zhigang Wu, Jiangnan Yao, Siyi Wang, Lanzhi Duan, Sijia Liu, Mei Zhang, Yanhong Luo, Dongmei Ye, Yuxu Huang, Lan Chen, Ke Xu and Jianghua Zhou
    Citation: Cardiovascular Diabetology 2024 23:54
  23. Coronary heart disease (CHD) is a major global health concern, especially among individuals with type 2 diabetes (T2D). Given the crucial role of proteins in various biological processes, this study aimed to e...

    Authors: Hong Luo, Marie-Theres Huemer, Agnese Petrera, Stefanie M. Hauck, Wolfgang Rathmann, Christian Herder, Wolfgang Koenig, Annika Hoyer, Annette Peters and Barbara Thorand
    Citation: Cardiovascular Diabetology 2024 23:53
  24. The outcomes of percutaneous coronary intervention (PCI) in diabetic patients are still suboptimal, and it is unclear if diabetic patients might derive a benefit from the use of drug-coated balloons.

    Authors: Gianluca Caiazzo, Angelo Oliva, Luca Testa, Tay M. Heang, Chuey Y. Lee, Diego Milazzo, Giulio Stefanini, Nicola Pesenti, Antonio Mangieri, Antonio Colombo and Bernardo Cortese
    Citation: Cardiovascular Diabetology 2024 23:52
  25. It has been confirmed that the ApoB/ApoA1 ratio is closely associated with the incidence of cardiometabolic diseases (CMD). However, due to uncontrolled confounding factors in observational studies, the causal...

    Authors: Chao Fu, Dongbo Liu, Qi Liu, Xuedong Wang, Xiaoxue Ma, Hong Pan, Shi Feng, Zhao Sun, Weishen Qiao, Mengyue Yang, Shuang Gao, Hongyu Ding, Xingtao Huang and Jingbo Hou
    Citation: Cardiovascular Diabetology 2024 23:51
  26. Diabetes mellitus is a chronic disease which is detrimental to cardiovascular health, often leading to secondary microvascular complications, with huge global health implications. Therapeutic interventions tha...

    Authors: Monica Gamez, Hesham E. Elhegni, Sarah Fawaz, Kwan Ho Ho, Neill W. Campbell, David A. Copland, Karen L. Onions, Matthew J. Butler, Elizabeth J. Wasson, Michael Crompton, Raina D. Ramnath, Yan Qiu, Yu Yamaguchi, Kenton P. Arkill, David O. Bates, Jeremy E. Turnbull…
    Citation: Cardiovascular Diabetology 2024 23:50

    The Correction to this article has been published in Cardiovascular Diabetology 2024 23:74

  27. Diabetic cardiomyopathy (DbCM) is a form of Stage B heart failure (HF) at high risk for progression to overt disease. Using baseline characteristics of study participants from the Aldose Reductase Inhibition f...

    Authors: James L. Januzzi, Stefano Del Prato, Julio Rosenstock, Javed Butler, Justin Ezekowitz, Nasrien E. Ibrahim, Carolyn S.P. Lam, Thomas Marwick, W. H. Wilson Tang, Yuxi Liu, Reza Mohebi, Alessia Urbinati, Faiez Zannad and Riccardo Perfetti
    Citation: Cardiovascular Diabetology 2024 23:49
  28. The impact of the coexistence of type 2 diabetes mellitus (T2DM) in patients with non-ischemic dilated cardiomyopathy (DCM) on clinical profiles, myocardial fibrosis, and outcomes remain incompletely understood.

    Authors: Yangjie Li, Hong Xian, Yuanwei Xu, Weihao Li, Jiajun Guo, Ke Wan, Jie Wang, Ziqian Xu, Qing Zhang, Yuchi Han, Jiayu Sun and Yucheng Chen
    Citation: Cardiovascular Diabetology 2024 23:48
  29. Underweight imposes significant burden on cardiovascular outcomes in patients with diabetes mellitus. However, less is known about the impact of serial change in body weight status measured as body mass index ...

    Authors: Joo Hee Jeong, Yun Gi Kim, Kyung-Do Han, Seung-Young Roh, Hyoung Seok Lee, Yun Young Choi, Jaemin Shim, Jong-Il Choi and Young-Hoon Kim
    Citation: Cardiovascular Diabetology 2024 23:46
  30. This study used a bidirectional 2-sample Mendelian randomization study to investigate the potential causal links between mtDNA copy number and cardiometabolic disease (obesity, hypertension, hyperlipidaemia, t...

    Authors: Pei Qin, Tianhang Qin, Lei Liang, Xinying Li, Bin Jiang, Xiaojie Wang, Jianping Ma, Fulan Hu, Ming Zhang and Dongsheng Hu
    Citation: Cardiovascular Diabetology 2024 23:45
  31. The prognostic value of triglyceride-glucose (TyG) index in general type 2 diabetes mellitus (T2DM) patients is still unclear. Therefore, we aimed to determine the associations between TyG and all-cause/cause-...

    Authors: Younan Yao, Bo Wang, Tian Geng, Jiyan Chen, Wan Chen and Liwen Li
    Citation: Cardiovascular Diabetology 2024 23:43
  32. Asialoglycoprotein receptor 1 (ASGR1), primarily expressed on hepatocytes, promotes the clearance and the degradation of glycoproteins, including lipoproteins, from the circulation. In humans, loss-of-function...

    Authors: Monika Svecla, Lorenzo Da Dalt, Annalisa Moregola, Jasmine Nour, Andrea Baragetti, Patrizia Uboldi, Elena Donetti, Lorenzo Arnaboldi, Giangiacomo Beretta, Fabrizia Bonacina and Giuseppe Danilo Norata
    Citation: Cardiovascular Diabetology 2024 23:42
  33. It is well-known that systemic inflammation plays a crucial role in the pathogenesis and prognosis of acute myocardial infarction (AMI). The systemic immune-inflammation index (SII, platelet × neutrophil/lymph...

    Authors: Jiachen Luo, Xiaoming Qin, Xingxu Zhang, Yiwei Zhang, Fang Yuan, Wentao Shi, Baoxin Liu and Yidong Wei
    Citation: Cardiovascular Diabetology 2024 23:41
  34. The triglyceride-glucose (TyG) index is regarded as a dependable alternative for assessing insulin resistance (IR), given its simplicity, cost-effectiveness, and strong correlation with IR. The relationship be...

    Authors: Benchuan Hao, Lyu Lyu, Juan Xu, Xiaoqing Zhu, Cui Xu, Weiyang Gao, Ji Qin, Taoke Huang, Yipu Ding, Ziyue Zhang, Yanhui Yang and Hongbin Liu
    Citation: Cardiovascular Diabetology 2024 23:40
  35. The triglyceride-glucose (TyG) index has been linked to the onset, progression, and prognosis of cardiovascular disease (CVD) in middle-aged and elderly individuals. Nevertheless, the relationship between the ...

    Authors: Dachuan Guo, Zhenguo Wu, Fei Xue, Sha Chen, Xiangzhen Ran, Cheng Zhang and Jianmin Yang
    Citation: Cardiovascular Diabetology 2024 23:39
  36. Legume consumption has been linked to a reduced risk of type 2 diabetes (T2D) and cardiovascular disease (CVD), while the potential association between plasma metabolites associated with legume consumption and...

    Authors: Hernando J. Margara-Escudero, Indira Paz-Graniel, Jesús García-Gavilán, Miguel Ruiz-Canela, Qi Sun, Clary B. Clish, Estefania Toledo, Dolores Corella, Ramón Estruch, Emilio Ros, Olga Castañer, Fernando Arós, Miquel Fiol, Marta Guasch-Ferré, José Lapetra, Cristina Razquin…
    Citation: Cardiovascular Diabetology 2024 23:38
  37. Higher levels of palmitoyl sphingomyelin (PSM, synonymous with sphingomyelin 16:0) are associated with an increased risk of cardiovascular disease (CVD) in people with diabetes. Whether circulating PSM levels ...

    Authors: Xin Qian, Hongmei Jia, Jinping Wang, Siyao He, Meng Yu, Xinxing Feng, Qiuhong Gong, Yali An, Xuan Wang, Na Shi, Hui Li, Zhongmei Zou, Guangwei Li and Yanyan Chen
    Citation: Cardiovascular Diabetology 2024 23:37
  38. Type 2 diabetes mellitus (T2DM) increases the risk of coronary heart disease (CHD) by 2–4 fold, and is associated with endothelial dysfunction, dyslipidaemia, insulin resistance, and chronic hyperglycaemia. Th...

    Authors: Francesco Piarulli, Cristina Banfi, Eugenio Ragazzi, Erica Gianazza, Marco Munno, Massimo Carollo, Pietro Traldi, Annunziata Lapolla and Giovanni Sartore
    Citation: Cardiovascular Diabetology 2024 23:36
  39. Diabetes mellitus (DM) is associated with a worse prognosis in patients with heart failure. Our aim was to analyze the clinical and imaging features of patients with DM and their association with outcomes in c...

    Authors: Pablo Zulet, Fabián Islas, Marcos Ferrández-Escarabajal, Ana Bustos, Beatriz Cabeza, Sandra Gil-Abizanda, María Vidal, Irene Martín-Lores, Paula Hernández-Mateo, J. Alberto de Agustín and Carmen Olmos
    Citation: Cardiovascular Diabetology 2024 23:35
  40. Foot ulcers and/or infections are common long-term complications of diabetes and are associated with increased mortality, especially from cardiovascular disease, though only a few studies have investigated the...

    Authors: Martina Vitale, Emanuela Orsi, Anna Solini, Monia Garofolo, Veronica Resi, Enzo Bonora, Cecilia Fondelli, Roberto Trevisan, Monica Vedovato, Giuseppe Penno and Giuseppe Pugliese
    Citation: Cardiovascular Diabetology 2024 23:34
  41. Cardiovascular diseases (CVDs) remain a major global health concern, necessitating advanced risk assessment beyond traditional factors. Early vascular aging (EVA), characterized by accelerated vascular changes...

    Authors: Iván Cavero-Redondo, Alicia Saz-Lara, Irene Martínez-García, Iris Otero-Luis and Arturo Martínez-Rodrigo
    Citation: Cardiovascular Diabetology 2024 23:33
  42. Chen et al. recently related the skin autofluorescence (SAF) of Advanced Glycation End-products to subclinical cardiovascular disease in the 3001 participants from the general population (Rotterdam study), wit...

    Authors: Fadi Alkhami, Gauthier Borderie, Ninon Foussard, Alice Larroumet, Laurence Blanco, Marie-Amélie Barbet-Massin, Amandine Ferriere, Claire Ducos, Kamel Mohammedi, Sami Fawaz, Thierry Couffinhal and Vincent Rigalleau
    Citation: Cardiovascular Diabetology 2024 23:32
  43. Type 1 diabetes (T1D) is a significant risk factor for a range of cardiovascular diseases. Nonetheless, the causal relationship between T1D and non-ischemic cardiomyopathy (NICM) remains to be elucidated. Furt...

    Authors: Yunyue Zhao, Enxi Quan, Tao Zeng, Zhuoshan Huang, Yanting Luo, Long Peng, Suhua Li, Jinlai Liu, Yutian Chong and Hong Cao
    Citation: Cardiovascular Diabetology 2024 23:31
  44. Individuals who are overweight or obese often develop insulin resistance, mediation of the association between body mass index (BMI) and stroke risk through the triglyceride-glucose index (TyG) seems plausible...

    Authors: Rong-Rui Huo, Qian Liao, Lu Zhai, Xue-Mei You and Yan-Li Zuo
    Citation: Cardiovascular Diabetology 2024 23:30
  45. The stress hyperglycemia ratio (SHR) has been demonstrated as an independent risk factor for acute kidney injury (AKI) in certain populations. However, this relationship in patients with congestive heart failu...

    Authors: Le Li, Ligang Ding, Lihui Zheng, Lingmin Wu, Zhicheng Hu, Limin Liu and Yan Yao
    Citation: Cardiovascular Diabetology 2024 23:29
  46. The triglyceride-glucose (TyG) index, identified as a reliable indicator of insulin resistance (IR), was reported to be associated with stroke recurrence and morbidity in the general population and critically ...

    Authors: Zhendong Ding, Mian Ge, Yuexiang Tan, Chaojin Chen and Ziqing Hei
    Citation: Cardiovascular Diabetology 2024 23:27
  47. To investigate the correlation between triglyceride glucose index (TyG) and collateral circulation in patients with chronic total occlusion (CTO) of coronary arteries in different glucose metabolic states.

    Authors: Junwei Zhu, Minghui Niu, Chenxing Wang, Ying Liang, Rong Guo and Fei He
    Citation: Cardiovascular Diabetology 2024 23:26
  48. Females are generally less prone to cardiovascular (CV) events than males, but this protection is trumped by diabetes. The mechanism behind the increased relative risk in females with diabetes is not fully und...

    Authors: Alessia Riccio, Elena Fortin, Linda Mellbin, Anna Norhammar, Per Näsman, Lars Rydén, Giorgio Sesti and Giulia Ferrannini
    Citation: Cardiovascular Diabetology 2024 23:25

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    3,115 Altmetric mentions